ALCC.P — A-Labs Capital IV Income Statement
0.000.00%
Last trade - 00:00FinancialsMicro Cap
Annual income statement for A-Labs Capital IV, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.021 | 0.076 | 0.08 | 0.044 | 0.027 |
| Operating Profit | -0.021 | -0.076 | -0.08 | -0.044 | -0.027 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.021 | -0.076 | -0.08 | -0.044 | -0.029 |
| Net Income After Taxes | -0.021 | -0.076 | -0.08 | -0.044 | -0.029 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.021 | -0.076 | -0.08 | -0.044 | -0.029 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.021 | -0.076 | -0.08 | -0.044 | -0.029 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.011 | -0.038 | -0.04 | -0.022 | -0.014 |